Tuberculosis and TNF-α inhibitors in children: how to manage a fine balance

Since the introduction of biologic response modifiers (BRMs) in the management of children affected by the immune-mediated inflammatory disease, these patients substantially improved their quality of life. BRMs are generally well tolerated and effective in most children and adolescents refractory to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Biomed
Autores principales: Parigi, Sara, Licari, Amelia, Manti, Sara, Marseglia, Gian Luigi, Tosca, Maria Angela, Miraglia del Giudice, Michele, Caffarelli, Carlo, Calvani, Mauro, Martelli, Alberto, Cardinale, Fabio, Cravidi, Claudio, Duse, Marzia, Chiappini, Elena
Formato: Artigo
Lenguaje:Inglês
Publicado: Mattioli 1885 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023060/
https://ncbi.nlm.nih.gov/pubmed/33004779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v91i11-S.10311
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares